RFK Jr. Brings MAHA Crusade to Iowa as Biotech Investment Rules Tighten

Robert F. Kennedy Jr. took his Make America Healthy Again (MAHA) campaign to Iowa this week, drawing crowds with his signature mix of vaccine skepticism and promises to overhaul federal health agencies. The independent presidential hopeful is betting that his message on chronic disease, food policy, and medical freedom will resonate with Midwestern voters, even as he lags far behind in national polls. Kennedy's Iowa swing comes at a pivotal moment for his long-shot bid, as he fights to secure ballot access in all 50 states and qualify for upcoming debates. Meanwhile, Washington is moving to restrict U.S. investments in Chinese biotechnology, a policy shift that could ripple across the pharmaceutical and venture capital sectors. The proposed rules, expected to be finalized later this year, would limit American funding for companies developing cutting-edge therapies and genomic tools in China, citing national security concerns. Industry leaders warn that the move could slow cross-border collaboration and drive up costs for drug development. Kennedy has not commented directly on the biotech investment rules, but his broader critique of corporate influence in medicine aligns with growing bipartisan skepticism of foreign supply chains. As the campaign season heats up, both health policy and economic security are emerging as flashpoints that could shape the 2024 race. The convergence of Kennedy's populist health agenda and new federal restrictions signals a turbulent stretch ahead for the life sciences industry.